Can the Rally in $CVNA Continue?

The following article is sponsored by DrStoxx.com

"Helping active traders make money in the markets since 2002"

The Trend Trade Letter: +34% annual ROI since 2002

The Cheap Stocks Letter: +59% annual ROI since 2007

The ETF Trend Letter: +65% annual ROI since 2010

The Momentum Letter: +82% annual ROI since 2012

Carvana Co. (Nasdaq: CVNA) is one of the few bright spots in this year's rather dull crop of IPOs. Shares of the stock initially sold off following its first day of trading as investors were wary that its disruptive way of selling used cars (mail order? vending machine?) was more about gimmicks than real sales. But all that changed when the company reported record profits earlier this month. Shares shot up from around $9 to just over $20 in just 2 weeks. Today shares are holding to those highs and now investors are wondering: is this the real deal or will it fall back again?

Carvana Co. is trying to take the Amazon platform to the used car sales industry. You search for your next car online, but it online and finance it online (so far, so Autotrader.com). But the unique selling points of Carvana are: all cars are certified, there are no dealership markups (saving an average of $2200 per car), the car is delivered right to your door for free, and you have time to test drive it before committing yourself. All of these disruptors have caught media attention and earned the company a lot of buzz.

Let's look at the numbers: at the aforementioned earnings report, the company reported a growth in revenues of 118% to $159M (quarter). Over 8300 cars were sold, with 7700 cars in its inventory. That's not enough yet to turn a profit on its thin ...

Read More
Comments

Spicy $SAUC a Great Buy Here

Disclaimer: we are LONG shares of $SAUC in The Dr. Stoxx Options Letter (sold on Marketfy.com) and it is also a stock selected for previous issues of THE MOMENTUM LETTER as sold on DrStoxx.com.

Diversified Restaurant Holdings, Inc ...

Read More
Comments

$REGI: best clean energy play

The following stock was selected by our proprietary MOMENTUM-PEAR strategy. This method is featured in the new HOT STOXX LETTER, set to launch very soon. Limited enrollment: 200 max. subscribers. For more information, see below or email us at: support ...

Read More
Comments

$SNAP - The new $FB or the next $TWTR-like fail?

SPECIAL OFFER: To celebrate our 15th year publishing award winning stock pick letters, please use HALFOFF in the discount code box at checkout at www.drstoxx.com.

So is Snapchat (Nasdaq: SNAP) the next Facebook (+360% since IPO) or the ...

Read More
Comments

$SAUC - Time to Nibble on This Food Stock

We own shares of $SAUC in our private account.

$SAUC is one of the Top 3 Longs in The Momentum Letter as sold on DrStoxx.com. The Momentum Letter is published weekly and is our most profitable stock letter.

Diversified ...

Read More
Comments

Spartan Motors Racing Higher ($SPAR)

This stock pick was selected by The Momentum Letter Trading System. For more information on The Momentum Letter, please click here.

Spartan Motors (Nasdaq: SPAR)

Market Cap: $297M

Industry: Specialty Vehicles and Parts

Shares of Spartan Motors are up 63 ...

Read More
Comments

$TROX - Buy Before the Breakout

Market Talks with Dr. Stoxx

DrStoxx.com

NYSE: $TROX

Tronox Limited

Market Cap: $2.0B

NOTE: WE ARE LONG TROX IN THE DR. STOXX OPTIONS LETTER (click here)

Tronox produces and sells titanium based chemicals and pigments that have a ...

Read More
Comments

Conservative Momentum Pick: Centene (CNC)

Market Talks with Dr. Stoxx

DrStoxx.com

NYSE: CNC

Centene Corporation

Index: S&P 500

Market Cap: $13.1B

Centene works with governments to provide quality health care to those with little or no insurance. It is a component of the ...

Read More
Comments

Buy Aceto Before Earnings - $ACET

$ACET is a BUY.

This producer of chemicals used in generic drugs is a recent addition to our IXTHYS Letter Portfolio. The company produces $545M in revenues and shares trade at a low 22x earnings, and 9x forward estimates. Net ...

Read More
Comments

Buy Big Five Before the Big Squeeze - $BGFV

$BGFV Big Five Sporting Goods a sporting goods retailer with perfect valuation metrics and solid growth numbers. Shares trade at less than 20x earnings and only 12.4x next year's eps. The company has very little debt, pays a ...

Read More
Comments

Sportsman Warehouse: showing increasing strength

$SPWH

Sportman Warehouse is a beaten down sporting goods retailer on the buyout list, trading at super low PE, PEG and PS ratios. The company is growing with +220% return on equity. Analysts have a $6 price target. 27% of ...

Read More
Comments

Why this Smallcap Biotech Will Soar Soon!

Dr. Thomas Carr

March 24, 2017 10:38am

Cempra, Inc. (NASDAQ: CEMP) is an American, clinical-stage biotechnology company focused on developing anti-infectives for the acute care and communal diseases sectors. Its 2 lead products in the pipeline are Solithromycin, which ...

Read More
Comments